BIRC6
Basic information
Region (hg38): 2:32357023-32619571
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (507 variants)
- BIRC6-related_disorder (77 variants)
- not_provided (47 variants)
- Hereditary_breast_ovarian_cancer_syndrome (1 variants)
- Autism_spectrum_disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the BIRC6 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000016252.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 14 | 34 | 22 | 70 | ||
| missense | 541 | 13 | 11 | 565 | ||
| nonsense | 6 | 6 | ||||
| start loss | 0 | |||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 20 | 20 | ||||
| Total | 0 | 0 | 582 | 47 | 33 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| BIRC6 | protein_coding | protein_coding | ENST00000421745 | 74 | 261871 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 125558 | 0 | 51 | 125609 | 0.000203 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 3.21 | 1964 | 2.41e+3 | 0.816 | 0.000122 | 31421 |
| Missense in Polyphen | 694 | 1097.4 | 0.6324 | 14419 | ||
| Synonymous | -1.87 | 949 | 879 | 1.08 | 0.0000452 | 9686 |
| Loss of Function | 12.5 | 14 | 210 | 0.0666 | 0.0000108 | 2822 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000177 | 0.000177 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.0000547 | 0.0000544 |
| Finnish | 0.000194 | 0.000185 |
| European (Non-Finnish) | 0.000338 | 0.000317 |
| Middle Eastern | 0.0000547 | 0.0000544 |
| South Asian | 0.0000332 | 0.0000327 |
| Other | 0.000708 | 0.000653 |
dbNSFP
Source:
- Function
- FUNCTION: Anti-apoptotic protein which can regulate cell death by controlling caspases and by acting as an E3 ubiquitin-protein ligase. Has an unusual ubiquitin conjugation system in that it could combine in a single polypeptide, ubiquitin conjugating (E2) with ubiquitin ligase (E3) activity, forming a chimeric E2/E3 ubiquitin ligase. Its tragets include CASP9 and DIABLO/SMAC. Acts as an inhibitor of CASP3, CASP7 and CASP9. Important regulator for the final stages of cytokinesis. Crucial for normal vesicle targeting to the site of abscission, but also for the integrity of the midbody and the midbody ring, and its striking ubiquitin modification. {ECO:0000269|PubMed:14765125, ECO:0000269|PubMed:15200957, ECO:0000269|PubMed:18329369}.;
- Pathway
- Apoptosis - multiple species - Homo sapiens (human);Ubiquitin mediated proteolysis - Homo sapiens (human);Apoptosis Modulation and Signaling
(Consensus)
Recessive Scores
- pRec
- 0.0958
Intolerance Scores
- loftool
- 0.389
- rvis_EVS
- -4.33
- rvis_percentile_EVS
- 0.11
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.892
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- protein phosphorylation;ubiquitin-dependent protein catabolic process;apoptotic process;cell cycle;positive regulation of cell population proliferation;negative regulation of endopeptidase activity;protein ubiquitination;regulation of cytokinesis;regulation of cell population proliferation;negative regulation of apoptotic process;cell division;labyrinthine layer development;spongiotrophoblast layer development;negative regulation of extrinsic apoptotic signaling pathway
- Cellular component
- spindle pole;nucleus;endosome;trans-Golgi network;microtubule organizing center;membrane;midbody;Flemming body
- Molecular function
- ubiquitin-protein transferase activity;cysteine-type endopeptidase inhibitor activity;protein binding;ubiquitin conjugating enzyme activity